GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elixinol Wellness Ltd (ASX:EXL) » Definitions » Total Liabilities

Elixinol Wellness (ASX:EXL) Total Liabilities : A$5.25 Mil (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Elixinol Wellness Total Liabilities?

Elixinol Wellness's Total Liabilities for the quarter that ended in Dec. 2023 was A$5.25 Mil.

Elixinol Wellness's quarterly Total Liabilities declined from Dec. 2022 (A$4.33 Mil) to Jun. 2023 (A$3.73 Mil) but then increased from Jun. 2023 (A$3.73 Mil) to Dec. 2023 (A$5.25 Mil).

Elixinol Wellness's annual Total Liabilities declined from Dec. 2021 (A$6.26 Mil) to Dec. 2022 (A$4.33 Mil) but then increased from Dec. 2022 (A$4.33 Mil) to Dec. 2023 (A$5.25 Mil).


Elixinol Wellness Total Liabilities Historical Data

The historical data trend for Elixinol Wellness's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elixinol Wellness Total Liabilities Chart

Elixinol Wellness Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial 9.69 6.82 6.26 4.33 5.25

Elixinol Wellness Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.26 4.81 4.33 3.73 5.25

Elixinol Wellness Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Elixinol Wellness's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=4.988+(0.192+-7.7715611723761E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0.069)
=5.25

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=11.711-6.462
=5.25

Elixinol Wellness's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=4.988+(0.192+-7.7715611723761E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0.069)
=5.25

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=11.711-6.462
=5.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elixinol Wellness Total Liabilities Related Terms

Thank you for viewing the detailed overview of Elixinol Wellness's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Elixinol Wellness (ASX:EXL) Business Description

Traded in Other Exchanges
Address
680 George Street, Level 12, Sydney, NSW, AUS, 2000
Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the geographical segments of the Americas, Australia, Europe and other regions of which key revenue is derived from the Americas segment. The Americas segment includes the trading results of Elixinol LLC (Elixinol Americas) and its investments and joint ventures in the US through the manufacture and distribution of hemp-derived cannabidiol products.

Elixinol Wellness (ASX:EXL) Headlines

No Headlines